Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

INARCTICA completes SPO with oversubscription

11/30/23 AQUA

Rosneft reported for 9 months of 2023 by IFRS

11/30/23 ROSN

Salesforce reported for 9 months of fiscal year 2024

11/30/23 CRM

Rosneft increased gas production by 33%

11/30/23 ROSN

Bashneft reported for 9 months of 2023 by IFRS

11/30/23 BANE

Varioganneftegaz reported for 9 months of 2023 by RAS

11/29/23 VJGZ

RN-West Siberia reported for 9 months of 2023 by RAS

11/29/23 CHGZ

Transneft reported for 9 months of 2023 by IFRS

11/29/23 TRNFP

Saratov Refinery reported for 9 months of 2023 by RAS

11/29/23 KRKN

Aeroflot reported for 9 months of 2023 by IFRS

11/29/23 AFLT